Supplement GMP Documentation Better, But Still No. 2 On FDA Observation List – AHPA

FDA revisits about a third of supplement manufacturing sites, with two-thirds coming within three years, says AHPA. Chief information analyst Merle Zimmermann says FDA increased focus on recordkeeping has resulted in an improvement and fewer problems reported since 2015

The US Food and Drug Administration is revisiting about one-third of dietary supplement manufacturing facilities it inspects, most within three years, according to American Herbal Products Association data.

About two-thirds of facilities inspected more than once are revisited within about three years, said Merle Zimmermann, AHPA's chief information...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation